Biogen Inc. buy Royal Bank of Canada
Start price
19.09.24
/
50%
€180.40
Target price
19.09.25
€262.25
Performance (%)
-35.53%
Price
15:57
€116.30
Summary
This prediction is currently active. Massive losses of -35.53% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 19.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.225% | -0.225% |
| iShares Core DAX® | -1.184% | 0.861% |
| iShares Nasdaq 100 | 3.941% | 6.184% |
| iShares Nikkei 225® | -1.206% | -0.294% |
| iShares S&P 500 | 3.141% | 5.930% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $292.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat